Matheson, C. J., Casalvieri, K. A., Backos, D. S., & Reigan, P. (2018). Development of potent pyrazolopyrimidinone-based WEE1 inhibitors with limited single-agent cytotoxicity for cancer therapy. ChemMedChem.
Chicago Style CitationMatheson, Christopher J., Kimberly A. Casalvieri, Donald S. Backos, i Philip Reigan. "Development of Potent Pyrazolopyrimidinone-based WEE1 Inhibitors With Limited Single-agent Cytotoxicity for Cancer Therapy." ChemMedChem 2018.
Cita MLAMatheson, Christopher J., Kimberly A. Casalvieri, Donald S. Backos, i Philip Reigan. "Development of Potent Pyrazolopyrimidinone-based WEE1 Inhibitors With Limited Single-agent Cytotoxicity for Cancer Therapy." ChemMedChem 2018.
Atenció: Aquestes cites poden no estar 100% correctes.